Roche Holding | search
Click here to view Roche Holding news from 60+ newspapers.
Bookmark or Share- Novo Holdings’ purchase of Catalent set to close after regulators ...Novo Holdings can complete its $16.5 billion acquisition of contract drug manufacturer Catalent after antitrust regulators in the U.S. declined to challenge the deal before the expiry of a deadline, the companies said Saturday. ... the CEOs of both Roche and Eli Lilly expressed skepticism over its fairness — unusual intra-industry criticism.
- Roche Holding AG, ROG:SWX summary - FT.com - Financial TimesLatest Roche Holding AG (ROG:SWX) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.
- About RocheSince our founding over 125 years ago, Roche has grown into one of the world’s largest biotech companies, as well as a leading provider of in-vitro diagnostics and a global supplier of transformative innovative solutions across major disease areas.
- Roche | Roche’s Annual Report 2023CEO Roche Group. Discover how Roche made an impact in 2023. Discover our innovative journey in revolutionising patient care and how we’ve impacted millions worldwide. Explore our Annual Report to see our strides in pharmaceuticals and diagnostics. Roche Group sales: CHF 58.7 billion. Pharmaceuticals Division sales: CHF 44.6 billion
- Roche Holding AG (RHHBY) Stock Price & Overview - Stock AnalysisGet the latest Roche Holding AG (RHHBY) stock price quote with financials, statistics, dividends, charts and more.
More
